New drug combo may replace harsh transplant for hodgkin lymphoma patients

NCT ID NCT05502250

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a new drug called tislelizumab combined with chemotherapy for people whose Hodgkin lymphoma has returned or not responded to initial treatment. The goal is to see if this approach works as well as the standard intensive chemotherapy and stem cell transplant. About 75 adults with confirmed Hodgkin lymphoma will receive the drug combo, and those who achieve complete remission will continue on tislelizumab alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

classic Hodgkin lymphoma Hodgkins lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • BE-Bruxelles-STLUC

    Brussels, Belgium

  • DK-Aarhus N-AUH

    Aarhus, Denmark

  • DK-Copenhagen-RIGSHOSPITALET

    Copenhagen, Denmark

  • DK-Odense-OUH

    Odense, Denmark

  • NL-Amersfoort-MEANDERMC

    Amersfoort, Netherlands

  • NL-Amsterdam-AMC

    Amsterdam, Netherlands

  • NL-Arnhem-RIJNSTATE

    Arnhem, Netherlands

  • NL-Den Haag-HAGA

    The Hague, Netherlands

  • NL-Eindhoven-MAXIMAMC

    Eindhoven, Netherlands

  • NL-Goes-ADRZ

    Goes, Netherlands

  • NL-Groningen-UMCG

    Groningen, Netherlands

  • NL-Hoofddorp-SPAARNEGASTHUIS

    Hoofddorp, Netherlands

  • NL-Leeuwarden-MCL

    Leeuwarden, Netherlands

  • NL-Maastricht-MUMC

    Maastricht, Netherlands

  • NL-Rotterdam-ERASMUSMC

    Rotterdam, Netherlands